Walgreens Boots Alliance Inc., US9314271084

Walgreens Boots Alliance stock holds near yearly lows

Published on 09/22/2026 at 11:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Walgreens Boots Alliance stock traded at USD 11.13 on September 21, 2026, while its latest quarter showed a 10.4 percent revenue decline. Fiscal 2026 guidance remains central.

Fotorealistischer Blick auf einen namenlosen Freizeitpark mit einer großen roten Looping-Achterbahn, feiernden Besuchern und Palmen bei goldenem Abendlicht — Disney US9314271084 zeigt einen bunten generischen Freizeitpark mit farbenprächtiger Achterbahn bei goldenem Sonnenuntergang, Illustration mit AI erstellt.

Walgreens Boots Alliance stock traded at USD 11.13 on the NYSE on September 21, 2026, according to the latest completed trading session. The valuation remains tied to the pharmacy chain's latest reported quarter and its fiscal 2026 outlook.

Revenue pressure shapes the story

Walgreens Boots Alliance reported revenue of USD 39.5 billion for the third quarter of fiscal 2026, down 10.4 percent from USD 44.1 billion in the year-earlier period, according to the company's investor-relations materials. The comparison makes the operating challenge concrete: lower sales, rather than only valuation sentiment, remains the central earnings issue.

Adjusted earnings per share were USD 0.11 in the third quarter of fiscal 2026, compared with USD 0.63 in the prior-year quarter. That decline of USD 0.52 per share leaves less room for the company to absorb pressure from pharmacy reimbursement, prescription volume and retail demand.

Cash flow and guidance matter

For fiscal 2026, Walgreens Boots Alliance maintained a reported adjusted earnings-per-share outlook of USD 1.55 to USD 1.65. The range is materially below the prior-year operating profile, so the market is likely to weigh execution against the lower base rather than revenue alone.

The latest trading price of USD 11.13 on September 21, 2026, provides the market reference for that debate. At that level, the stock remains a low-priced large-cap healthcare retailer, but the earnings comparison shows why a lower share price does not by itself resolve the operating risk.

Stock stays tied to execution

Walgreens Boots Alliance stock closed at USD 11.13 on the NYSE as of September 21, 2026. The next meaningful valuation signal is the company's ability to stabilize quarterly revenue while delivering the fiscal 2026 earnings range.